Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Strategies of antiretroviral therapy in adults.
Itani S, Bartlett JA. Itani S, et al. Among authors: bartlett ja. Urol Clin North Am. 1999 Nov;26(4):809-20, ix-x. doi: 10.1016/s0094-0143(05)70221-4. Urol Clin North Am. 1999. PMID: 10584621 Review.
HIV infection: treatment outcomes in older and younger adults.
Wellons MF, Sanders L, Edwards LJ, Bartlett JA, Heald AE, Schmader KE. Wellons MF, et al. Among authors: bartlett ja. J Am Geriatr Soc. 2002 Apr;50(4):603-7. doi: 10.1046/j.1532-5415.2002.50152.x. J Am Geriatr Soc. 2002. PMID: 11982658
Changes in CD4+ T-cell differentiation phenotype during structured treatment interruption in patients with chronic HIV-1 infection.
Alexander TH, Ortiz GM, Wellons MF, Allen A, Grace EJ 2nd, Schweighardt B, Brancato J, Sandberg JK, Furlan SN, Miralles GD, Nixon DF, Bartlett JA. Alexander TH, et al. Among authors: bartlett ja. J Acquir Immune Defic Syndr. 2003 Dec 15;34(5):475-81. doi: 10.1097/00126334-200312150-00005. J Acquir Immune Defic Syndr. 2003. PMID: 14657757
Persistent antiretroviral activity of nucleoside analogues after prolonged zidovudine and lamivudine therapy as demonstrated by rapid loss of activity after discontinuation.
Eron JJ Jr, Bartlett JA, Santana JL, Bellos NC, Johnson J, Keller A, Kuritzkes DR, St Clair MH, Johnson VA. Eron JJ Jr, et al. Among authors: bartlett ja. J Acquir Immune Defic Syndr. 2004 Dec 15;37(5):1581-3. doi: 10.1097/00126334-200412150-00009. J Acquir Immune Defic Syndr. 2004. PMID: 15577413 Clinical Trial.
Long-term results of initial therapy with abacavir and Lamivudine combined with Efavirenz, Amprenavir/Ritonavir, or Stavudine.
Bartlett JA, Johnson J, Herrera G, Sosa N, Rodriguez A, Liao Q, Griffith S, Irlbeck D, Shaefer MS; Clinically Significant Long-Term Antiretroviral Sequential Sequencing Study (CLASS) Team. Bartlett JA, et al. J Acquir Immune Defic Syndr. 2006 Nov 1;43(3):284-92. doi: 10.1097/01.qai.0000243092.40490.26. J Acquir Immune Defic Syndr. 2006. PMID: 16967040 Clinical Trial.
230 results